ESC 365 - The change in HDL proteomics following lipid-apheresis therapy

ESC Premium Access

The change in HDL proteomics following lipid-apheresis therapy

Session: Poster Session 6 - Preventive cardiology / Lipids

Topic: Lipids, Other

Speaker: Doctor P. Moriarty (Kansas City, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Patrick Moriarty

University of Kansas Medical Center, Kansas City (United States of America)

2 presentations

0 follower

20 more presentations in this session

Disconcordance between ESC prevention guidelines and observed lipid profiles in patients with known coronary artery disease

Speaker: Doctor I. Dykun (Essen, DE)

Statin treatment after acute coronary syndrome: long-term persistence and reasons for non-persistence

Speaker: Doctor D. Huber (Umea, SE)

Predictive value of omega-3 polyunsaturated fatty acids (PUFAs) for cardiovascular- and all-cause mortality in chronic haemodialysis patients

Speaker: Doctor Y. Kumada (Kasamatsu, JP)

The association between apolipoprotein A1 and HDL-cholesterol with acute myocardial infarction is modified by plasma choline. A cohort study of patients with suspected stable angina pectoris

Speaker: Doctor G. Svingen (Bergen, NO)

Post-prandial remnant lipoprotein metabolism in sitosterolemia

Speaker: Doctor H. Tada (Kanazawa, JP)

Access the full session

Poster Session 6 - Preventive cardiology / Lipids

Speakers: Doctor P. Moriarty, Doctor I. Dykun, Doctor D. Huber, Doctor Y. Kumada, Doctor G. Svingen...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources